Synageva Biopharma Corp (NASDAQ:GEVA) Investor Investigation of Buyout by Alexion Pharmaceuticals, Inc
An investigation on behalf of investors, who currently hold shares of Synageva Biopharma Corp (NASDAQ:GEVA), was announced concerning whether the takeover of Synageva Biopharma Corp by Alexion Pharmaceuticals, Inc for a value of approximately $230.00 per share is unfair to NASDAQ:GEVA stockholders.
View full press release